Kiniksa Pharmaceuticals to Present at Wells Fargo Healthcare Conference

LONDON, Sept. 04, 2026 /CourierPR/ -- Kiniksa Pharmaceuticals, a biopharmaceutical company focused on developing treatments for debilitating diseases, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. Eastern Time. The presentation will be available live through the company’s website at www.kiniksa.com, and a replay will be accessible within 48 hours post-event.

The company, which is dedicated to discovering, acquiring, developing, and commercializing novel therapies for unmet medical needs, particularly in cardiovascular conditions, will present at the conference. Kiniksa’s portfolio includes assets based on strong biologic rationale, promising differentiation potential, and validated mechanisms.

For those interested in accessing the live webcast, the Investors section of Kiniksa’s website offers the opportunity. Additionally, Kiniksa’s portfolio of therapies aims to provide innovative solutions for patients suffering from diseases with unmet medical needs.

The presentation is part of Kiniksa's ongoing commitment to advancing medical research and patient care. The company’s focus on cardiovascular indications underscores its mission to improve patient outcomes through cutting-edge therapies.